To improve security and privacy, we are moving our web pages and services from HTTP to HTTPS.
To give users of web services time to transition to HTTPS, we will support separate HTTP and HTTPS services until the end of 2017.
From January 2018 most HTTP traffic will be automatically redirected to HTTPS. [more...]
View this page in https
PROSITE documentation PDOC50191

CRAL-TRIO lipid binding domain profile





Description

The CRAL-TRIO domain is a structurally conserved element of about 170 amino acids, which constitute a hydrophobic lipid binding pocket. The CRAL-TRIO domain is found in GTPase-activating proteins (GAPs), guanine nucleotide exchange factors (GEFs) and a family of hydrophobic ligand binding proteins, including the yeast SEC14 protein and mammalian retinaldehyde- and α-tocopherol-binding proteins. The CRAL-TRIO domain may either constitute all of the protein or only part of it [1,2,3,4,5].

The resolution of the crystal structure of SEC14 has revealed the structure of the CRAL-TRIO lipid binding domain (see <PDB:1AUA>). The CRAL-TRIO lipid binding domain is an α/β domain, which forms a large hydrophobic pocket. The pocket floor is constituted by six β-strands and the sides of the cavity are formed by α-helices [3].

Some proteins known to contain a CRAL-TRIO domain are listed below:

  • Yeast phosphatidylinositol-transfer protein (SEC14). It is required for transport of secretory proteins from the golgi complex in vivo and it catalyzes the transfer of phosphatidylinositol and phosphatidylcholine between membranes in vitro.
  • Animal retinal-binding protein.
  • Animal neurofibromin (protein NF-1). In human, defects in NF-1 are the cause of type 1 neurofibromatosis (NF-1), one of the most frequent autosomal dominant diseases.
  • Mammalian BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 (NIP2). NIP2 is an apoptosis regulator.
  • Mammalian guanine nucleotide exchange factor DBS (DBL's big sister).
  • Mammalian cellular retinol retinaldehyde-binding protein (CRALBP). It carries 11-cis-retinol and 11-cis-retinaldehyde as endogenous ligands and may be a functional component of the visual cycle.
  • Mammalian α-tocopherol transfer protein (α-TTP). It binds α- tocopherol and enhances its transfer between separate membranes.
  • Mammalian α-tocopherol-associated protein (TAP).

The profile we developed covers the entire CRAL-TRIO domain.

Last update:

June 2002 / First entry.

Technical section

PROSITE method (with tools and information) covered by this documentation:

CRAL_TRIO, PS50191; CRAL-TRIO lipid binding domain profile  (MATRIX)


References

1AuthorsSalama S.R., Cleves A.E., Malehorn D.E., Whitters E.A., Bankaitis V.A.
TitleCloning and characterization of Kluyveromyces lactis SEC14, a gene whose product stimulates Golgi secretory function in Saccharomyces cerevisiae.
SourceJ. Bacteriol. 172:4510-4521(1990).
PubMed ID2198263

2AuthorsSato Y., Arai H., Miyata A., Tokita S., Yamamoto K., Tanabe T., Inoue K.
TitlePrimary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular retinaldehyde-binding protein.
SourceJ. Biol. Chem. 268:17705-17710(1993).
PubMed ID8349655

3AuthorsSha B., Phillips S.E., Bankaitis V.A., Luo M.
TitleCrystal structure of the Saccharomyces cerevisiae phosphatidylinositol-transfer protein.
SourceNature 391:506-510(1998).
PubMed ID9461221
DOI10.1038/35179

4AuthorsAravind L., Neuwald A.F., Ponting C.P.
TitleSec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signaling.
SourceCurr. Biol. 9:R195-R197(1999).
PubMed ID10209105

5AuthorsZimmer S., Stocker A., Sarbolouki M.N., Spycher S.E., Sassoon J., Azzi A.
TitleA novel human tocopherol-associated protein: cloning, in vitro expression, and characterization.
SourceJ. Biol. Chem. 275:25672-25680(2000).
PubMed ID10829015
DOI10.1074/jbc.M000851200



PROSITE is copyright. It is produced by the SIB Swiss Institute Bioinformatics. There are no restrictions on its use by non-profit institutions as long as its content is in no way modified. Usage by and for commercial entities requires a license agreement. For information about the licensing scheme send an email to
Prosite License or see: prosite_license.html.

Miscellaneous

View entry in original PROSITE document format
View entry in raw text format (no links)